Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Q Su

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancerE G Shaw, R L Deming, E T Creagan, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 1999
Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjectsJ V Fahy, D W Cockcroft, L P Boulet, et al.
Cancer|March 15, 1995
Prophylactic cranial irradiation in limited-stage small cell lung cancerV Liengswangwong, J A Bonner, E G Shaw, et al.
Cancer|July 15, 1993
Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinomaJ S Brindle, E G Shaw, J Q Su, et al.
Cancer|February 15, 1994
Phase II trial of edatrexate in small cell lung cancerM Wiesenfeld, J R Jett, J Q Su, et al.
Journal of the National Cancer Institute|February 17, 1993
Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lungE G Shaw, W L McGinnis, J R Jett, et al.
Cancer Research|October 1, 1993
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomasM K Dodson, L C Hartmann, W A Cliby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Prognostic significance of p53 immunostaining in epithelial ovarian cancerL C Hartmann, K C Podratz, G L Keeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapyV Liengswangwong, J A Bonner, E G Shaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trialA W Maksymiuk, J R Jett, J D Earle, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancerE G Shaw, R L Deming, E T Creagan, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 1999
Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjectsJ V Fahy, D W Cockcroft, L P Boulet, et al.
Cancer|March 15, 1995
Prophylactic cranial irradiation in limited-stage small cell lung cancerV Liengswangwong, J A Bonner, E G Shaw, et al.
Cancer|July 15, 1993
Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinomaJ S Brindle, E G Shaw, J Q Su, et al.
Cancer|February 15, 1994
Phase II trial of edatrexate in small cell lung cancerM Wiesenfeld, J R Jett, J Q Su, et al.
Journal of the National Cancer Institute|February 17, 1993
Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lungE G Shaw, W L McGinnis, J R Jett, et al.
Cancer Research|October 1, 1993
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomasM K Dodson, L C Hartmann, W A Cliby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Prognostic significance of p53 immunostaining in epithelial ovarian cancerL C Hartmann, K C Podratz, G L Keeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapyV Liengswangwong, J A Bonner, E G Shaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trialA W Maksymiuk, J R Jett, J D Earle, et al.
Pageof 4